查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1843657

2025年全球醫療診斷人工智慧市場報告

Artificial Intelligence in Healthcare Diagnosis Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，人工智慧在醫療診斷領域的市場規模呈指數級成長，從2024年的231.8億美元成長到2025年的330.3億美元，複合年成長率達42.5%。預測期內的成長歸因於醫學影像技術的進步、資料可近性和數位化、臨床工作流程的最佳化、研發投資以及醫療專業人員的短缺。

預計未來幾年，人工智慧在醫療診斷領域的市場規模將呈指數級成長，到2029年將達到1534億美元，年複合成長率（CAGR）高達46.8%。預測期內的成長主要得益於人工智慧賦能的精準醫療、與電子健康記錄的整合、醫學影像分析的擴展、穿戴式健康技術的興起、監管支持以及標準化。預測期內的關鍵趨勢包括：可解釋人工智慧在醫療保健領域的應用、人工智慧驅動的早期疾病檢測、遠端保健整合、人工智慧在病理學和組織病理學領域的應用，以及人工智慧賦能的照護現場診斷。

人工智慧（AI）在醫療診斷領域的應用，是指將機器學習和深度學習演算法等人工智慧技術應用於疾病診斷。人工智慧能夠快速評估包括實驗室檢測結果、醫療記錄和基因資訊在內的各種數據，與傳統的人工診斷方法相比，能夠為醫療專業人員提供更快捷的診斷。

人工智慧在醫療診斷領域的主要組成部分包括軟體、服務和硬體。軟體是程式、資料和指令的集合，旨在在電腦和電子設備上執行特定任務。這些組成部分應用於多種醫學診斷，包括心臟病學、腫瘤學、病理學、放射學、胸腔肺科和神經病學。診斷方式包括磁振造影造影 (MRI)、電腦斷層掃描 (CT)、X光和超音波，可用於體內和體外診斷。最終用戶包括醫院、影像診斷中心和診斷實驗室。

美國2025年關稅上調及其引發的貿易緊張局勢正對資訊科技產業產生重大影響，尤其是在硬體製造、資料基礎設施和軟體部署方面。進口半導體、電路基板和網路設備的關稅提高，並推高了高科技公司、雲端服務供應商和資料中心的生產和營運成本。在全球範圍內採購筆記型電腦、伺服器和消費電子產品零件的公司面臨更長的前置作業時間週期和價格壓力。同時，對專用軟體徵收的關稅以及主要國際市場的報復性措施擾亂了全球IT供應鏈，並降低了海外對美國製造技術的需求。為了應對這些挑戰，該行業正在加大對國內晶片生產的投資，擴大供應商網路，並利用人工智慧驅動的自動化技術來增強韌性並更有效地控制成本。

這份《醫療診斷人工智慧市場研究報告》是商業研究公司最新報告系列的一部分，提供醫療診斷人工智慧市場統計數據，包括全球市場規模、區域佔有率、競爭對手及其市場佔有率、詳細的市場細分、市場趨勢和商業機會。本市場研究報告對該行業的現狀和未來發展趨勢進行了深入分析，為您提供所需的一切全面觀點。

未來五年46.8%的預測成長率較我們先前對該市場的預測略微下降了0.2%。這一下降主要歸因於美國與其他國家之間的關稅影響。關稅將增加採購和維護人工智慧影像處理和分析平台的維修成本，這可能會影響美國診所的診斷準確性。此外，由於相互關稅以及貿易緊張局勢和限制措施升級對全球經濟和貿易造成的負面影響，其影響範圍將更加廣泛。

人工智慧（AI）在醫療診斷領域的市場成長預期主要受慢性病盛行率上升的驅動。慢性病具有長期進展和間歇性持續的特點，並有望受益於人工智慧在醫療診斷領域的變革性影響。這項技術可望顯著改善疾病管理、診斷和資源利用，從而降低成本。人工智慧可以增強醫療專業人員的決策能力，識別高風險患者，並幫助他們提供更個人化的照護。例如，世界衛生組織（WHO）在2022年9月報告稱，每年將有4,100萬人死亡，其中74%的死亡將歸因於非傳染性疾病（NCD）或慢性病。這些死亡包括1,790萬人死於心血管疾病，930萬人死於癌症，410萬人死於慢性呼吸道疾病，以及200萬人死於糖尿病。因此，慢性病盛行率的上升是推動人工智慧在醫療診斷市場成長的主要因素。

預計未來遠距遠端醫療的日益普及將推動人工智慧在醫療診斷市場的發展。遠距遠端醫療是指利用視訊會議、語音通話和其他數位通訊工具等通訊技術遠端提供醫療保健服務。遠端醫療的興起正在推動醫療診斷領域對人工智慧的需求。人工智慧工具可以幫助醫療服務提供者根據患者報告的症狀和數據進行遠距離診斷。例如，2023年4月，美國非營利組織FAIR Health（致力於提高醫療成本和保險資訊的透明度）報告稱，全美遠端醫療使用量年增7.3%，其中純音頻遠距遠端醫療服務在農村地區的普及率高於都市區。因此，遠距遠端醫療領域的不斷擴展正在推動人工智慧在醫療診斷市場的發展。

技術進步已成為醫療診斷人工智慧市場中一個引人注目的趨勢，並且正在迅速發展。該市場的主要企業正積極致力於開發創新技術以保持競爭力。例如，2023年3月，總部位於法國的生物技術公司Genomic Vision推出了FiberSmart，這是一款由人工智慧驅動的軟體，旨在自動檢測和量化梳狀DNA（去氧核糖核酸）分子上的螢光訊號。 FiberSmart擁有使用者友善的介面，能夠快速分析DNA複製訊號並提取描述複煞車力學的關鍵參數。憑藉先進的人工智慧技術，FiberSmart超越了Genomic Vision現有的軟體解決方案，將DNA複煞車力學的可視化、檢測和評估的準確性提高了三倍，同時速度提高了十倍。該軟體符合人體工學的設計提升了用戶體驗，使用戶能夠快速分析DNA複製訊號並推導出解釋複煞車力學的關鍵變數。

醫療診斷人工智慧市場的關鍵參與者正致力於開發創新解決方案，重點關注基於人工智慧的疾病檢測。這涉及利用人工智慧技術分析醫療數據，例如影像、患者記錄和診斷測試，以識別和檢測各種疾病和健康狀況。例如，2023年5月，總部位於美國的下一代創投工作室Aegis Ventures LLC與美國醫療科技公司Northwell Holdings合作推出了「OptAIn」。 OptAIn利用攜帶式簡易視網膜相機拍攝的眼部影像，其人工智慧不僅可以篩檢眼部疾病，還可以辨識全身140多種其他疾病。其目標是在這些疾病的早期、最容易治療的階段進行檢測。

2022年10月，美國臨床診斷公司貝克曼庫爾特診斷公司（Beckman Coulter Diagnostics）完成了對StoCastic LLC的收購，具體金額未揭露。 StoCastic的TriageGo將成為貝克曼庫爾特人工智慧驅動的臨床決策支援（CDS）產品組合的核心。這一新興領域旨在透過向醫生提供數據驅動的洞察並最佳化臨床決策，從而提升患者護理水平。 StoCastic LLC是一家總部位於美國的人工智慧公司，專注於開發人工智慧工具，以幫助醫療服務提供者更準確、更有效率地進行疾病診斷。

人工智慧在醫療保健診斷市場的主要參與者包括強生私人有限公司、英特爾公司、國際商業機器公司、美敦力公司、英偉達公司、西門子醫療保健有限公司、皇家飛利浦公司、通用電氣醫療集團、愛克發-吉華集團、GoogleDeepMind、Babylon Health、HeartFlow Inc、Corti 、Agidoc, Nidr. Inc.、Enlitic Inc.、NovaSignal Corp.、Cleerly Inc.、Butterfly Network Inc.、IBM Watson Health、Arterys Inc.、Zebra Medical Vision Inc.、Vuno Inc.、RiverAIn Technologies、CloudMedX Inc.和Neural Analytics Inc.。

2024年，北美是醫療保健診斷人工智慧市場最大的地區。醫療保健診斷人工智慧市場報告涵蓋的地區包括亞太地區、西歐、東歐、北美、南美以及中東和非洲。

醫療保健診斷人工智慧市場報告涵蓋的國家包括澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、義大利、西班牙和加拿大。

醫療診斷領域的人工智慧（AI）市場由提供醫學影像分析、基因分析、臨床決策支援、風險預測和分層等服務的營業單位所獲得的收入所構成。市場價值還包括服務供應商銷售的或包含在其服務產品中的相關產品的價值。此外，醫療診斷領域的人工智慧（AI）市場還包括用於提供醫療診斷人工智慧服務的手術機器人和視覺工具的銷售額。此市場價值為“出廠價”，即製造商或生產商銷售給其他營業單位（包括下游製造商、經銷商和零售商）或直接銷售給最終客戶的商品價值。該市場中的商品價值還包括商品製造商提供的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球人工智慧在醫療診斷中的應用：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 終端用戶產業分析
  • 全球醫療診斷人工智慧市場：成長率分析
  • 全球醫療診斷人工智慧市場表現：規模與成長，2019-2024年
  • 全球醫療診斷人工智慧市場預測：規模與成長，2024-2029年，2034年
  • 全球醫療診斷人工智慧：潛在市場規模 (TAM)

第6章 市場細分

  • 全球醫療診斷人工智慧市場：按組件、效能和預測分類，2019-2024年、2024-2029年、2034年
  • 軟體
  • 服務
  • 硬體
  • 全球醫療診斷人工智慧市場：依診斷類型、效能和預測分類，2019-2024年、2024-2029年、2034年
  • 心臟病學
  • 腫瘤學
  • 病理
  • 放射科
  • 胸部/肺部
  • 神經病學
  • 其他
  • 全球醫療診斷人工智慧市場按模式、效能和預測分類，2019-2024年、2024-2029年、2034年
  • 磁振造影（MRI）
  • CT（電腦斷層掃描）
  • X光
  • 超音波
  • 全球醫療診斷人工智慧市場：按應用、效能和預測分類，2019-2024年、2024-2029年、2034年
  • 體內診斷
  • 體外診斷
  • 全球醫療診斷人工智慧市場（按最終用戶、效能和預測分類，2019-2024年、2024-2029年、2034年）
  • 醫院
  • 診斷影像中心
  • 診斷實驗室
  • 其他
  • 全球醫療診斷人工智慧市場：軟體細分、按類型分類、實際結果和預測（2019-2024年、2024-2029年、2034年）
  • 診斷軟體
  • 影像分析軟體
  • 預測分析軟體
  • 全球醫療診斷人工智慧市場：服務細分、按類型分類、實際結果和預測（2019-2024年、2024-2029年、2034年）
  • 諮詢服務
  • 實施服務
  • 維護和支援服務
  • 全球醫療診斷人工智慧市場：硬體細分、類型、實際結果和預測（2019-2024年、2024-2029年、2034年）
  • 診斷影像設備
  • 人工智慧驅動的醫療設備
  • 資料儲存和處理硬體

第7章 區域和國家分析

  • 全球醫療診斷人工智慧市場：按地區、績效和預測分類，2019-2024年、2024-2029年、2034年
  • 全球醫療診斷人工智慧市場：國家、表現與預測，2019-2024年、2024-2029年、2034年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 人工智慧在醫療診斷市場的應用：競爭格局
  • 人工智慧在醫療診斷市場的應用：公司概況
    • Johnson and Johnson Private Limited Overview, Products and Services, Strategy and Financial Analysis
    • Intel Corporation Overview, Products and Services, Strategy and Financial Analysis
    • International Business Machines Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic Overview, Products and Services, Strategy and Financial Analysis
    • Nvidia Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Siemens Healthcare GmbH
  • Koninklijke Philips NV
  • GE Healthcare
  • Agfa-Gevaert Group
  • Google Deep Mind
  • Babylon Health
  • HeartFlow Inc.
  • Corti HQ
  • Aidoc
  • Aidoc Medical Ltd.
  • Imagen Technologies
  • AliveCor Inc.
  • Digital Diagnostics Inc.
  • Enlitic Inc.
  • NovaSignal Corp.

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

  • 2029年醫療診斷人工智慧市場：提供新機會的國家
  • 2029年醫療診斷人工智慧市場：新興細分市場機會
  • 2029年醫療診斷人工智慧市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章附錄

簡介目錄
Product Code: r24687u

Artificial intelligence (AI) in healthcare diagnosis involves the application of AI techniques, such as machine learning and deep learning algorithms, for the purpose of diagnosing medical conditions. The utilization of AI allows for the rapid evaluation of data, encompassing clinical trials, medical records, and genetic information, providing medical practitioners with a quicker diagnosis compared to traditional human methods.

The primary components incorporated in artificial intelligence in healthcare diagnosis consist of software, services, and hardware. Software is a compilation of programs, data, and instructions designed to execute specific tasks on a computer or electronic device. These components are utilized across various medical diagnoses, including cardiology, oncology, pathology, radiology, chest and lung, neurology, and others. The modalities involved comprise MRI (magnetic resonance imaging), CT (computed tomography), X-ray, and ultrasound, catering to applications in both in vivo and in vitro diagnostics. The end-users benefiting from these AI applications include hospitals, diagnostic imaging centers, diagnostic laboratories, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the ensuing trade tensions in spring 2025 are having a significant impact on the information technology sector, especially in hardware manufacturing, data infrastructure, and software deployment. Increased duties on imported semiconductors, circuit boards, and networking equipment have driven up production and operating costs for tech companies, cloud service providers, and data centers. Firms that depend on globally sourced components for laptops, servers, and consumer electronics are grappling with extended lead times and mounting pricing pressures. At the same time, tariffs on specialized software and retaliatory actions by key international markets have disrupted global IT supply chains and dampened foreign demand for U.S.-made technologies. In response, the sector is ramping up investments in domestic chip production, broadening its supplier network, and leveraging AI-powered automation to improve resilience and manage costs more effectively.

The artificial intelligence in healthcare diagnosis market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence in healthcare diagnosis market statistics, including artificial intelligence in healthcare diagnosis industry global market size, regional shares, competitors with an artificial intelligence in healthcare diagnosis market share, detailed artificial intelligence in healthcare diagnosis market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in healthcare diagnosis industry. This artificial intelligence in healthcare diagnosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence in healthcare diagnosis market size has grown exponentially in recent years. It will grow from $23.18 billion in 2024 to $33.03 billion in 2025 at a compound annual growth rate (CAGR) of 42.5%. The growth in the historic period can be attributed to advancements in medical imaging, data accessibility and digitization, clinical workflow optimization, research and development investments, shortage of healthcare professionals.

The artificial intelligence in healthcare diagnosis market size is expected to see exponential growth in the next few years. It will grow to $153.4 billion in 2029 at a compound annual growth rate (CAGR) of 46.8%. The growth in the forecast period can be attributed to ai-powered precision medicine, integration with electronic health records, expansion of medical imaging analysis, rise of wearable health tech, regulatory support and standards. Major trends in the forecast period include explainable ai in healthcare, ai-driven early disease detection, telehealth integration, ai in pathology and histopathology, ai-enabled point-of-care diagnostics.

The forecast of 46.8% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Diagnostic accuracy in U.S. clinics could be affected as tariffs make AI-supported imaging and analysis platforms more expensive to procure and maintain. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated growth in the artificial intelligence (AI) in healthcare diagnosis market is driven by the increasing incidence rate of chronic diseases. Chronic diseases, characterized by their long-term progression and intermittent persistence, are expected to benefit from the transformative impact of AI in healthcare diagnosis. This technology holds the potential for significant improvements in disease management, diagnosis, and resource utilization, leading to cost savings. AI can empower medical practitioners to enhance decision-making, identify patients at risk, and deliver more personalized care. For example, in September 2022, the World Health Organization reported 41 million deaths annually, with 74% attributed to non-communicable diseases (NCDs) or chronic diseases globally. These included 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. Consequently, the rising incidence of chronic diseases is a key driver of the growth in the artificial intelligence in the healthcare diagnosis market.

The growing use of telemedicine is expected to drive the growth of artificial intelligence in the healthcare diagnosis market in the future. Telemedicine involves using telecommunications technologies, such as video conferencing, audio calls, and other digital communication tools, to deliver medical care and services remotely. The rise of telemedicine has led to increased demand for AI in healthcare diagnosis. AI tools can assist healthcare providers in making remote diagnoses based on patient-reported symptoms and data. For example, in April 2023, FAIR Health, a US-based nonprofit organization focused on promoting transparency in healthcare costs and insurance information, reported a 7.3% increase in national telehealth utilization compared to the previous year, with audio-only telehealth services being more prevalent in rural areas than in urban ones. Thus, the growing telemedicine landscape is driving the expansion of artificial intelligence in the healthcare diagnosis market.

Technological advancement stands out as a prominent trend gaining traction in the artificial intelligence in the healthcare diagnosis market. Leading companies in this market are actively focusing on the development of innovative technologies to maintain their competitive edge. For instance, in March 2023, Genomic Vision, a biotechnology company based in France, unveiled FiberSmart, an AI-powered software designed to automate the detection and quantification of fluorescent signals on combed DNA (Deoxyribonucleic acid) molecules. Boasting a user-friendly interface, FiberSmart facilitates rapid analysis of DNA replication signals, extracting crucial parameters that describe replication kinetics. Employing advanced AI techniques, FiberSmart surpasses Genomic Vision's existing software solutions, offering up to three times more accurate visualization, detection, and evaluation of DNA replication kinetics, all achieved up to ten times faster. The software's ergonomic design enhances user convenience, enabling swift analysis of DNA replication signals to derive essential variables describing replication kinetics.

Major players in the artificial intelligence in the healthcare diagnosis market are directing their efforts toward the development of innovative solutions, with a focus on AI-powered disease detection. This involves leveraging artificial intelligence technologies to analyze medical data, including images, patient records, and diagnostic tests, for the identification and detection of various diseases or health conditions. For example, in May 2023, Aegis Ventures LLC, a next-generation venture studio based in the US, partnered with Northwell Holdings, a US-based medical technology company, to introduce 'Optain'. Utilizing images of the eye captured with a simple, portable retinal camera, Optain's AI not only screens for eye-related conditions but also identifies 140 diseases throughout the body. The goal is to detect these diseases at the earliest stage when they are most treatable.

In October 2022, Beckman Coulter Diagnostics, a US-based clinical diagnostics company, completed the acquisition of StoCastic LLC for an undisclosed amount. StoCastic's TriageGo is set to become the cornerstone of Beckman Coulter's AI-powered Clinical Decision Support (CDS) portfolio. This evolving discipline aims to enhance patient care by providing physicians with data-driven insights and optimizing clinical decision-making. StoCastic LLC, an artificial intelligence company based in the US, specializes in developing AI-powered tools for healthcare providers to achieve more accurate and efficient disease diagnoses.

Major companies operating in the artificial intelligence in healthcare diagnosis market include Johnson and Johnson Private Limited, Intel Corporation, International Business Machines Corporation, Medtronic, Nvidia Corporation, Siemens Healthcare GmbH, Koninklijke Philips N.V., GE Healthcare, Agfa-Gevaert Group, Google Deep Mind, Babylon Health, HeartFlow Inc., Corti HQ, Aidoc, Aidoc Medical Ltd., Imagen Technologies, AliveCor Inc., Digital Diagnostics Inc., Enlitic Inc., NovaSignal Corp., Cleerly Inc., Butterfly Network Inc., IBM Watson Health, Arterys Inc., Zebra Medical Vision Inc., Vuno Inc., Riverain Technologies, CloudMedX Inc., Neural Analytics Inc.

North America was the largest region in the artificial intelligence in healthcare diagnosis market in 2024. The regions covered in the artificial intelligence in healthcare diagnosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the artificial intelligence in healthcare diagnosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The artificial intelligence (AI) in healthcare diagnosis market consists of revenues earned by entities by providing medical imaging analysis, genetic analysis, clinical decision support, risk prediction and stratification. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial Intelligence (AI) in the healthcare diagnosis market also includes sales of surgical robots and visual tools which are used in providing AI in healthcare diagnosis services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence in Healthcare Diagnosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence in healthcare diagnosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence in healthcare diagnosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence in healthcare diagnosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Component: Software; Services; Hardware
  • 2) By Diagnosis: Cardiology; Oncology; Pathology; Radiology; Chest And Lung; Neurology; Other Diagnoses
  • 3) By Modality: MRI (Magnetic Resonance Imaging); CT (Computed Tomography); X-ray; Ultrasound
  • 4) By Application: In Vivo Diagnostics; In Vitro Diagnostics
  • 5) By End-User: Hospitals; Diagnostics Imaging Centers; Diagnostics Laboratories; Other End-Users
  • Subsegments:
  • 1) By Software: Diagnostic Software; Imaging Analysis Software; Predictive Analytics Software
  • 2) By Services: Consulting Services; Implementation Services; Maintenance And Support Services
  • 3) By Hardware: Diagnostic Imaging Devices; AI-Powered Medical Devices; Data Storage And Processing Hardware
  • Companies Mentioned: Johnson and Johnson Private Limited; Intel Corporation; International Business Machines Corporation; Medtronic; Nvidia Corporation; Siemens Healthcare GmbH; Koninklijke Philips N.V.; GE Healthcare; Agfa-Gevaert Group; Google Deep Mind; Babylon Health; HeartFlow Inc.; Corti HQ; Aidoc; Aidoc Medical Ltd.; Imagen Technologies; AliveCor Inc.; Digital Diagnostics Inc.; Enlitic Inc.; NovaSignal Corp.; Cleerly Inc.; Butterfly Network Inc.; IBM Watson Health; Arterys Inc.; Zebra Medical Vision Inc.; Vuno Inc.; Riverain Technologies; CloudMedX Inc.; Neural Analytics Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Intelligence in Healthcare Diagnosis Market Characteristics

3. Artificial Intelligence in Healthcare Diagnosis Market Trends And Strategies

4. Artificial Intelligence in Healthcare Diagnosis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Intelligence in Healthcare Diagnosis Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Artificial Intelligence in Healthcare Diagnosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Artificial Intelligence in Healthcare Diagnosis Market Growth Rate Analysis
  • 5.4. Global Artificial Intelligence in Healthcare Diagnosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Artificial Intelligence in Healthcare Diagnosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Artificial Intelligence in Healthcare Diagnosis Total Addressable Market (TAM)

6. Artificial Intelligence in Healthcare Diagnosis Market Segmentation

  • 6.1. Global Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Software
  • Services
  • Hardware
  • 6.2. Global Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiology
  • Oncology
  • Pathology
  • Radiology
  • Chest And Lung
  • Neurology
  • Other Diagnoses
  • 6.3. Global Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • MRI (Magnetic Resonance Imaging)
  • CT (Computed Tomography)
  • X-ray
  • Ultrasound
  • 6.4. Global Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • In Vivo Diagnostics
  • In Vitro Diagnostics
  • 6.5. Global Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostics Imaging Centers
  • Diagnostics Laboratories
  • Other End-Users
  • 6.6. Global Artificial Intelligence in Healthcare Diagnosis Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Software
  • Imaging Analysis Software
  • Predictive Analytics Software
  • 6.7. Global Artificial Intelligence in Healthcare Diagnosis Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Consulting Services
  • Implementation Services
  • Maintenance And Support Services
  • 6.8. Global Artificial Intelligence in Healthcare Diagnosis Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Imaging Devices
  • AI-Powered Medical Devices
  • Data Storage And Processing Hardware

7. Artificial Intelligence in Healthcare Diagnosis Market Regional And Country Analysis

  • 7.1. Global Artificial Intelligence in Healthcare Diagnosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Artificial Intelligence in Healthcare Diagnosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence in Healthcare Diagnosis Market

  • 8.1. Asia-Pacific Artificial Intelligence in Healthcare Diagnosis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence in Healthcare Diagnosis Market

  • 9.1. China Artificial Intelligence in Healthcare Diagnosis Market Overview
  • 9.2. China Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence in Healthcare Diagnosis Market

  • 10.1. India Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence in Healthcare Diagnosis Market

  • 11.1. Japan Artificial Intelligence in Healthcare Diagnosis Market Overview
  • 11.2. Japan Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence in Healthcare Diagnosis Market

  • 12.1. Australia Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence in Healthcare Diagnosis Market

  • 13.1. Indonesia Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence in Healthcare Diagnosis Market

  • 14.1. South Korea Artificial Intelligence in Healthcare Diagnosis Market Overview
  • 14.2. South Korea Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence in Healthcare Diagnosis Market

  • 15.1. Western Europe Artificial Intelligence in Healthcare Diagnosis Market Overview
  • 15.2. Western Europe Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence in Healthcare Diagnosis Market

  • 16.1. UK Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence in Healthcare Diagnosis Market

  • 17.1. Germany Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence in Healthcare Diagnosis Market

  • 18.1. France Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence in Healthcare Diagnosis Market

  • 19.1. Italy Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence in Healthcare Diagnosis Market

  • 20.1. Spain Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence in Healthcare Diagnosis Market

  • 21.1. Eastern Europe Artificial Intelligence in Healthcare Diagnosis Market Overview
  • 21.2. Eastern Europe Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence in Healthcare Diagnosis Market

  • 22.1. Russia Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence in Healthcare Diagnosis Market

  • 23.1. North America Artificial Intelligence in Healthcare Diagnosis Market Overview
  • 23.2. North America Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence in Healthcare Diagnosis Market

  • 24.1. USA Artificial Intelligence in Healthcare Diagnosis Market Overview
  • 24.2. USA Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence in Healthcare Diagnosis Market

  • 25.1. Canada Artificial Intelligence in Healthcare Diagnosis Market Overview
  • 25.2. Canada Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence in Healthcare Diagnosis Market

  • 26.1. South America Artificial Intelligence in Healthcare Diagnosis Market Overview
  • 26.2. South America Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence in Healthcare Diagnosis Market

  • 27.1. Brazil Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence in Healthcare Diagnosis Market

  • 28.1. Middle East Artificial Intelligence in Healthcare Diagnosis Market Overview
  • 28.2. Middle East Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence in Healthcare Diagnosis Market

  • 29.1. Africa Artificial Intelligence in Healthcare Diagnosis Market Overview
  • 29.2. Africa Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Artificial Intelligence in Healthcare Diagnosis Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence in Healthcare Diagnosis Market Competitive Landscape And Company Profiles

  • 30.1. Artificial Intelligence in Healthcare Diagnosis Market Competitive Landscape
  • 30.2. Artificial Intelligence in Healthcare Diagnosis Market Company Profiles
    • 30.2.1. Johnson and Johnson Private Limited Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Intel Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. International Business Machines Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Medtronic Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Nvidia Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence in Healthcare Diagnosis Market Other Major And Innovative Companies

  • 31.1. Siemens Healthcare GmbH
  • 31.2. Koninklijke Philips N.V.
  • 31.3. GE Healthcare
  • 31.4. Agfa-Gevaert Group
  • 31.5. Google Deep Mind
  • 31.6. Babylon Health
  • 31.7. HeartFlow Inc.
  • 31.8. Corti HQ
  • 31.9. Aidoc
  • 31.10. Aidoc Medical Ltd.
  • 31.11. Imagen Technologies
  • 31.12. AliveCor Inc.
  • 31.13. Digital Diagnostics Inc.
  • 31.14. Enlitic Inc.
  • 31.15. NovaSignal Corp.

32. Global Artificial Intelligence in Healthcare Diagnosis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence in Healthcare Diagnosis Market

34. Recent Developments In The Artificial Intelligence in Healthcare Diagnosis Market

35. Artificial Intelligence in Healthcare Diagnosis Market High Potential Countries, Segments and Strategies

  • 35.1 Artificial Intelligence in Healthcare Diagnosis Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Artificial Intelligence in Healthcare Diagnosis Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Artificial Intelligence in Healthcare Diagnosis Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer